Hint mode is switched on Switch off
For swift navigation between sections

Argenx
LEI 7245009C5FZE6G9ODQ71

PDF download

Choose all Reset all
Download Cancel
Organization name
Argenx S.E.
Country name
Netherlands
Country of registration
Netherlands
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Argenx S.E., a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer.

Awards

News

07/05/2026 Argenx (NASDAQ: ARGX) Exceeds Q1 Expectations with Strong Financial Performance
16/12/2025 Argenx SE (NASDAQ:ARGX) Faces Setback in Phase 3 Thyroid Eye Disease Studies
31/07/2025 argenx SE (NASDAQ:ARGX) Financial Performance and Strategic Advancements
23/07/2025 Morgan Stanley Flags 15 Earnings Movers to Watch: Magnificent 7 Still Driving S&P 500 Growth
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
2018
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    7245009C5FZE6G9ODQ71
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001697862
Registration is required to get access.